437 related articles for article (PubMed ID: 31367720)
1. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity.
Jung DJ; Shin TH; Kim M; Sung CO; Jang SJ; Jeong GS
Lab Chip; 2019 Sep; 19(17):2854-2865. PubMed ID: 31367720
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids.
Choi SY; Cho YH; Kim DS; Ji W; Choi CM; Lee JC; Rho JK; Jeong GS
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572899
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
4. Drug Sensitivity Assays of Human Cancer Organoid Cultures.
Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ
Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132
[TBL] [Abstract][Full Text] [Related]
5. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
6. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
7. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week.
Hu Y; Sui X; Song F; Li Y; Li K; Chen Z; Yang F; Chen X; Zhang Y; Wang X; Liu Q; Li C; Zou B; Chen X; Wang J; Liu P
Nat Commun; 2021 May; 12(1):2581. PubMed ID: 33972544
[TBL] [Abstract][Full Text] [Related]
9. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
[TBL] [Abstract][Full Text] [Related]
10. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
12. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer.
Xu Z; Gao Y; Hao Y; Li E; Wang Y; Zhang J; Wang W; Gao Z; Wang Q
Biomaterials; 2013 May; 34(16):4109-4117. PubMed ID: 23473962
[TBL] [Abstract][Full Text] [Related]
13. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
Takahashi N; Hoshi H; Higa A; Hiyama G; Tamura H; Ogawa M; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
Cells; 2019 May; 8(5):. PubMed ID: 31137590
[TBL] [Abstract][Full Text] [Related]
14. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Kim M; Mun H; Sung CO; Cho EJ; Jeon HJ; Chun SM; Jung DJ; Shin TH; Jeong GS; Kim DK; Choi EK; Jeong SY; Taylor AM; Jain S; Meyerson M; Jang SJ
Nat Commun; 2019 Sep; 10(1):3991. PubMed ID: 31488816
[TBL] [Abstract][Full Text] [Related]
16. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
Burkhart RA; Baker LA; Tiriac H
Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
[TBL] [Abstract][Full Text] [Related]
17. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
18. Long-term expanding human airway organoids for disease modeling.
Sachs N; Papaspyropoulos A; Zomer-van Ommen DD; Heo I; Böttinger L; Klay D; Weeber F; Huelsz-Prince G; Iakobachvili N; Amatngalim GD; de Ligt J; van Hoeck A; Proost N; Viveen MC; Lyubimova A; Teeven L; Derakhshan S; Korving J; Begthel H; Dekkers JF; Kumawat K; Ramos E; van Oosterhout MF; Offerhaus GJ; Wiener DJ; Olimpio EP; Dijkstra KK; Smit EF; van der Linden M; Jaksani S; van de Ven M; Jonkers J; Rios AC; Voest EE; van Moorsel CH; van der Ent CK; Cuppen E; van Oudenaarden A; Coenjaerts FE; Meyaard L; Bont LJ; Peters PJ; Tans SJ; van Zon JS; Boj SF; Vries RG; Beekman JM; Clevers H
EMBO J; 2019 Feb; 38(4):. PubMed ID: 30643021
[TBL] [Abstract][Full Text] [Related]
19. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
20. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.
Mazzocchi AR; Rajan SAP; Votanopoulos KI; Hall AR; Skardal A
Sci Rep; 2018 Feb; 8(1):2886. PubMed ID: 29440675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
